AQR Capital Management - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,986,000
-32.7%
12,292
-28.6%
0.00%
-40.0%
Q1 2021$2,951,000
-34.5%
17,225
-16.0%
0.01%
-37.5%
Q4 2020$4,502,000
+112.7%
20,495
+60.7%
0.01%
+100.0%
Q3 2020$2,117,000
+14.4%
12,750
-21.4%
0.00%
+33.3%
Q2 2020$1,851,000
+58.2%
16,213
+6.5%
0.00%
+50.0%
Q1 2020$1,170,000
-33.6%
15,220
+11.4%
0.00%0.0%
Q4 2019$1,761,000
+89.4%
13,664
+14.4%
0.00%
+100.0%
Q3 2019$930,000
-28.4%
11,939
-5.3%
0.00%0.0%
Q2 2019$1,299,000
+11.6%
12,612
-20.6%
0.00%0.0%
Q1 2019$1,164,000
-63.0%
15,875
-78.6%
0.00%
-75.0%
Q4 2018$3,148,000
-23.5%
74,211
-15.1%
0.00%0.0%
Q3 2018$4,117,000
+57.8%
87,420
+65.2%
0.00%
+33.3%
Q2 2018$2,609,000
+2589.7%
52,919
+100.0%
0.00%
Q2 2017$97,000
-29.7%
26,4640.0%0.00%
Q1 2017$138,000
-49.3%
26,464
-53.8%
0.00%
Q4 2016$272,000
-41.6%
57,337
-18.7%
0.00%
-100.0%
Q3 2016$466,000
+88.7%
70,532
+512.0%
0.00%
Q1 2016$247,000
-39.5%
11,525
-10.6%
0.00%
-100.0%
Q4 2015$408,000
-10.7%
12,892
-2.9%
0.00%0.0%
Q3 2015$457,000
+16.6%
13,281
+6.7%
0.00%0.0%
Q2 2015$392,00012,4510.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$116,595,21681.37%
ORACLE INVESTMENT MANAGEMENT INC 201,400$7,488,0527.25%
Paradigm Biocapital Advisors LP 1,396,779$51,932,2434.92%
Octagon Capital Advisors LP 750,000$27,885,0004.01%
Boxer Capital, LLC 2,000,000$74,3603.65%
Artal Group S.A. 1,537,709$57,1723.40%
Avoro Capital Advisors LLC 5,555,555$206,555,5353.06%
RTW INVESTMENTS, LP 3,643,114$135,450,9792.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 244,000$9,071,9202.53%
Kynam Capital Management, LP 499,853$18,584,5352.40%
View complete list of MIRATI THERAPEUTICS INC shareholders